SLP(SLP)
SLP
ANALYST COVERAGE7 analysts
BUY
▲ +319.8%upside to target
L $47.00
Med $56.00consensus
H $65.00PRICE
Prev Close
13.38
Open
13.56
Day Range13.22 – 13.68
13.22
13.68
52W Range11.09 – 34.01
11.09
34.01
10% of range
VOLUME & SIZE
Avg Volume
330.9K
FUNDAMENTALS
P/E Ratio
-4.3x
Not profitable
EPS (TTM)
—
Div Yield
0.01%
Beta
1.15
Market-like
TECHNICAL
RSI (14)
51
Bullish momentum
Upcoming Events
EEarnings Report
Tomorrow
May 19
DEx-Dividend
In 88 days
Aug 14
PDividend Pay
In 105 days
Aug 31
Key MetricsTTM
Market Cap$269.54M
Revenue TTM$80.53M
Net Income TTM-$62.79M
Free Cash Flow$23.77M
Gross Margin62.0%
Operating Margin-83.5%
Net Margin-78.0%
Return on Equity-49.3%
Return on Assets-42.9%
Debt / Equity0.00
Current Ratio5.47
EPS TTM$-3.12
SLP News
About
Simulations Plus, Inc., is a leading provider of modeling and simulation software and consulting services supporting drug discovery, development research, and regulatory submissions. With its subsidiaries, Cognigen, DILIsym Services, and Lixoft, we offer solutions which bridge machine learning, physiologically based pharmacokinetics, quantitative systems pharmacology/toxicology, and population PK/PD modeling approaches. The company's technology is licensed and applied by major pharmaceutical, biotechnology, chemical, consumer goods companies and regulatory agencies worldwide.
Industry
Computer Systems Design Services
Website
Bud NelsonVice President of Corporate Counsel & Personal Data Protection Officer
John Anthony DiBellaChief Revenue Officer
Josh FoheyChief Operating Officer
Shawn O'ConnorChief Executive Officer
Steven ChangGlobal Head of Strategic Alliances
William FrederickCFO, Executive VP & Corporate Secretary
Christina HendricksonSenior Director of Corporate Marketing
Jennifer PresnellAccounting Manager
Jill Fiedler-KellyPresident of Services Solutions
Viera LukacovaChief Science Officer